Livzon Mabpharm is a Chinese biotechnology company focused on the development, manufacture, and sale of antibody-based drugs.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 27, 2018 | Series A | — | 1 | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Apr 16, 2014
Epirus Biopharmaceuticals
|
Series B | $36M | Biotechnology | Yes |